New cohort added to the ongoing CARDINAL Phase 1/2 study to evaluate TERN-701 500mg QD in approximately 20 patients with BCR-ABL resistance mutations including T315I, M244V, F359I/C/V and others ...

Detailed price information for Applovin Corp Cl A (APP-Q) from The Globe and Mail including charting and trades.

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europe from France’s Institut ...

Investing.com — After three consecutive years of double-digit gains, the S&P 500 entered 2026 much as it left off in 2025—hovering just below record highs, alongside several major equity markets ...

CM Yogi Adityanath gifted PM Narendra Modi a pink enamel Shri Ram Temple replica, highlighting Kashi's Gulabi Meenakari, ODOP ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Airfare can be one of the most expensive parts of traveling. Apps make it easy to track trends in fare prices, look for deals and book flights. Some apps are completely free to use while others may ...

Choose between a layout optimized for your Android or Kindle tablet, or a replica experience that looks just like the newspaper available on newsstands Access to all content from the print edition, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Allied Bank (ABL) has delivered a 47.69% change over the past year, with a 52-week range between 122.00 and 219.80. What Is the Average Daily Trading Volume of Allied Bank (ABL)? The average daily ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today provided an update on recent business highlights and financial performance for 2025 and ...